CLLS ▼ -1.0% - Cellectis S.A. $CLLS - Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026 27-OCT-2026 03:15 AM ET